Education
About Us
Working with TipRanks
Follow Us
Irhythm Technologies (IRTC)
NASDAQ:IRTC
IRTC Stock Chart & Stats
$155.44
-$0.21(-0.23%)
At close: 4:00 PM EST
$155.44
-$0.21(-0.23%)
Day’s Range― - ―
52-Week Range$92.52 - $212.00
Previous CloseN/A
Volume94.23K
Average Volume (3M)473.44K
Market Cap
$5.26B
Enterprise Value$5.70B
Total Cash (Recent Filing)$565.21M
Total Debt (Recent Filing)$733.01M
Price to Earnings (P/E)―
Beta0.73
Next Earnings
Feb 19, 2026EPS Estimate
0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.16
Shares Outstanding32,219,143
10 Day Avg. Volume612,338
30 Day Avg. Volume473,439
Financial Highlights & Ratios
PEG Ratio2.45
Price to Book (P/B)30.94
Price to Sales (P/S)4.75
P/FCF Ratio-92.07
Enterprise Value/Market Cap1.08
Enterprise Value/Revenue8.11
Enterprise Value/Gross Profit11.53
Enterprise Value/Ebitda-375.00
Forecast
1Y Price Target
$222.64Price Target Upside43.23% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14
EPS Forecast (FY)-0.51
Revenue Forecast (FY)$865.18M
Bulls Say, Bears Say
Bulls Say
Analyst RatingsAddition to a leading analyst conviction list and maintained Buy ratings signal renewed analyst confidence in the company's growth outlook and valuation.
EHR Integration And AdoptionDeeper electronic health record integration and full-platform deployments at customer sites are increasing device utilization and supporting account expansion.
Product Pipeline And Market ExpansionAnticipated regulatory clearance and launch of a mobile cardiac monitoring product, combined with moves into sleep apnea and primary care channels, could broaden the addressable market and diversify revenue streams.
Bears Say
Cost Structure And ScalabilityBusiness cost structure may not be optimized for continuous 24-hour monitoring, raising concerns about margin pressure and scalability as longer-duration services expand.
Product Launch DelayDelay in the commercial rollout of the next-generation monitoring product has reduced near-term revenue expectations and could slow growth momentum.
Reimbursement Policy UncertaintyConflicting language in proposed local coverage determinations and potential misapplication of mobile telemetry guidelines create reimbursement uncertainty that may constrain provider utilization.
Irhythm Technologies News
IRTC FAQ
What was Irhythm Technologies’s price range in the past 12 months?
Irhythm Technologies lowest stock price was $92.52 and its highest was $212.00 in the past 12 months.
What is Irhythm Technologies’s market cap?
Irhythm Technologies’s market cap is $5.26B.
When is Irhythm Technologies’s upcoming earnings report date?
Irhythm Technologies’s upcoming earnings report date is Feb 19, 2026 which is in 35 days.
How were Irhythm Technologies’s earnings last quarter?
Irhythm Technologies released its earnings results on Oct 30, 2025. The company reported -$0.16 earnings per share for the quarter, beating the consensus estimate of -$0.324 by $0.164.
Is Irhythm Technologies overvalued?
According to Wall Street analysts Irhythm Technologies’s price is currently Undervalued.
Does Irhythm Technologies pay dividends?
Irhythm Technologies does not currently pay dividends.
What is Irhythm Technologies’s EPS estimate?
Irhythm Technologies’s EPS estimate is 0.01.
How many shares outstanding does Irhythm Technologies have?
Irhythm Technologies has 32,219,143 shares outstanding.
What happened to Irhythm Technologies’s price movement after its last earnings report?
Irhythm Technologies reported an EPS of -$0.16 in its last earnings report, beating expectations of -$0.324. Following the earnings report the stock price went up 1.727%.
Which hedge fund is a major shareholder of Irhythm Technologies?
Currently, no hedge funds are holding shares in IRTC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Irhythm Technologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$222.64 (43.23% Upside)
$222.64 (43.23% Upside)
Blogger Sentiment
Bullish
IRTC Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 484.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.3%
Last 30 Days ▲ 34.3%
Last 30 Days ▲ 34.3%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
64.87%
12-Months-Change
Fundamentals
Return on Equity
-53.15%
Trailing 12-Months
Asset Growth
9.40%
Trailing 12-Months
Company Description
Irhythm Technologies
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
IRTC Company Deck
IRTC Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call demonstrated strong financial performance and strategic growth through revenue increase, successful product expansion, and positive cash flow. However, there are challenges regarding regulatory interactions due to external factors.View all IRTC earnings summariesIRTC Stock 12 Month Forecast
Average Price Target
$222.64
▲(43.23% Upside)
Technical Analysis
Ownership Overview
Currently, No data available
---